Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

this regimen. Prognosis: Mild episodes hardly aff ect mortality; if severe, mortality ≈ 50% at 30d. 1yr after admission for alcoholic hepatitis, 40% are dead...a sobering thought. __OOHHCCMM__1100ee..iinnddbb 228811 0022//0055//22001177 1199::0077 ygoloretneortsaG 282 Primary biliary cholangitis (PBC) Interlobular bile ducts are damaged by chronic autoimmune granul omato us31 in- fl ammation causing cholestasis which may lead to fi brosis, cirrhosis, and portal hypertension. Cause Unknown environmental triggers (?pollutants, xenobiotics, non-pathogenic bacteria) + genetic predisposition (eg IL12A locus) leading to loss of immune tolerance to self-mitochondrial proteins. Antimitochondrial antibodies (AMA) are the hallmark of PBC. Prevalence 4/100 000. : ≈ 9:1. Risk  if +ve fam- ily history (seen in 1–6%); many UTIS; smoking; past pregnancy; other auto immune diseases;  use of nail polish/hair dye. Typical age at presentation ~50yrs. The patient Often asymptomatic and diagnosed after incidental fi nding ALP. Leth- argy, sleepiness, and pruritus may precede jaundice by years. Signs: Jaundice; skin pigmentation; xanthelasma (p691); xantho mata; hepatosplenomegaly. Complica- tions: Those of cirrhosis (p276); osteoporosis is common. Malabsorption of fat-soluble vitamins (A, D, E, K) due to cholestasis and bilirubin in the gut lumen results in osteo- malacia and coagu lopathy; HCC (p286). Tests Blood: ALP, GT, and
